Keratomycosis Caused by a Rare Pathogen, Myrothecium verrucaria

Mycopathologia. 2021 Dec;186(6):893-895. doi: 10.1007/s11046-021-00587-5. Epub 2021 Aug 29.

Abstract

Purpose: To report a case of keratomycosis caused by a very rare pathogen, Myrothecium verrucaria.

Methods: This is a case report. A 53-year-old man complaint of left eye redness, irritation, intermittent pain after ashes entered his left eye. The patient was examined by slit lamp, anterior segment OCT and in vivo confocal microscopy. The HRT III-RCM image showed massive interlocking white thin lines in the cornea stroma. Corneal scrapings were collected for pathogen culture and PCR test. M. verrucaria was isolated and identified.

Results: Hourly topical natamycin (5%) and voriconazole (10 mg/ml) was given as well as intravenous fluconazole (200 mg per day). Treatment was continued with oral itraconazole, 200 mg/day, topical natamycin (5%), 4 times/day, and pranoprofen, 4 times/day. The therapy was tapered off over one and half a month. The cornea lesion healed with scar formation two months later.

Conclusions: This is the first case report of M. verrucaria keratomycosis in China. We are the first to show the characteristic of M. verrucaria on cornea with In vivo confocal microscopy. A combination treatment of tropical natamycin, voriconazole and systemic fluconazole was effective in the treatment of M. verrucaria.

Keywords: Case report; Fungal keratitis; Keratomycosis; Myrothecium verrucaria.

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / therapeutic use
  • Eye Infections, Fungal* / diagnosis
  • Eye Infections, Fungal* / drug therapy
  • Humans
  • Hypocreales
  • Keratitis* / diagnosis
  • Keratitis* / drug therapy
  • Male
  • Middle Aged
  • Natamycin
  • Voriconazole

Substances

  • Antifungal Agents
  • Natamycin
  • Voriconazole

Supplementary concepts

  • Albifimbria verrucaria